Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Peptidyl-prolyl cis-trans isomerase A (Homo sapiens (Human)) | BDBM50230294 (CHEMBL4071740) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid PDB UniChem Similars | PDB Article PubMed | 4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selcia Ltd. Curated by ChEMBL | Assay Description Inhibition of full length recombinant human N-terminal His8-tagged Cyclophilin A (1 to 169 residues) expressed in Escherichia coli BL21(DE3) using Su... | J Med Chem 60: 1000-1017 (2017) Article DOI: 10.1021/acs.jmedchem.6b01329 BindingDB Entry DOI: 10.7270/Q2JQ137K | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
Peptidyl-prolyl cis-trans isomerase A (Homo sapiens (Human)) | BDBM50230211 (CHEMBL4063126) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | Article PubMed | 4.30 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selcia Ltd. Curated by ChEMBL | Assay Description Inhibition of full length recombinant human N-terminal His8-tagged Cyclophilin A (1 to 169 residues) expressed in Escherichia coli BL21(DE3) using Su... | J Med Chem 60: 1000-1017 (2017) Article DOI: 10.1021/acs.jmedchem.6b01329 BindingDB Entry DOI: 10.7270/Q2JQ137K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Peptidyl-prolyl cis-trans isomerase A (Homo sapiens (Human)) | BDBM50022815 ((3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase MCE KEGG MMDB PC cid PC sid UniChem Patents Similars | Article PubMed | 6.70 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selcia Ltd. Curated by ChEMBL | Assay Description Inhibition of full length recombinant human N-terminal His8-tagged Cyclophilin A (1 to 169 residues) expressed in Escherichia coli BL21(DE3) using Su... | J Med Chem 60: 1000-1017 (2017) Article DOI: 10.1021/acs.jmedchem.6b01329 BindingDB Entry DOI: 10.7270/Q2JQ137K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Peptidyl-prolyl cis-trans isomerase A (Homo sapiens (Human)) | BDBM50230212 (CHEMBL4084776) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid PDB UniChem Similars | PDB Article PubMed | 7 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selcia Ltd. Curated by ChEMBL | Assay Description Inhibition of full length recombinant human N-terminal His8-tagged Cyclophilin A (1 to 169 residues) expressed in Escherichia coli BL21(DE3) using Su... | J Med Chem 60: 1000-1017 (2017) Article DOI: 10.1021/acs.jmedchem.6b01329 BindingDB Entry DOI: 10.7270/Q2JQ137K | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
Peptidyl-prolyl cis-trans isomerase A (Homo sapiens (Human)) | BDBM50230213 (CHEMBL4092526) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid PDB UniChem Similars | PDB Article PubMed | 14 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selcia Ltd. Curated by ChEMBL | Assay Description Inhibition of full length recombinant human N-terminal His8-tagged Cyclophilin A (1 to 169 residues) expressed in Escherichia coli BL21(DE3) using Su... | J Med Chem 60: 1000-1017 (2017) Article DOI: 10.1021/acs.jmedchem.6b01329 BindingDB Entry DOI: 10.7270/Q2JQ137K | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
Peptidyl-prolyl cis-trans isomerase A (Homo sapiens (Human)) | BDBM50230210 (CHEMBL4090107) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid PDB UniChem | PDB Article PubMed | 16 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selcia Ltd. Curated by ChEMBL | Assay Description Inhibition of full length recombinant human N-terminal His8-tagged Cyclophilin A (1 to 169 residues) expressed in Escherichia coli BL21(DE3) using Su... | J Med Chem 60: 1000-1017 (2017) Article DOI: 10.1021/acs.jmedchem.6b01329 BindingDB Entry DOI: 10.7270/Q2JQ137K | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
Peptidyl-prolyl cis-trans isomerase A (Homo sapiens (Human)) | BDBM50230209 (CHEMBL4100272) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | 65 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selcia Ltd. Curated by ChEMBL | Assay Description Inhibition of full length recombinant human N-terminal His8-tagged Cyclophilin A (1 to 169 residues) expressed in Escherichia coli BL21(DE3) using Su... | J Med Chem 60: 1000-1017 (2017) Article DOI: 10.1021/acs.jmedchem.6b01329 BindingDB Entry DOI: 10.7270/Q2JQ137K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Peptidyl-prolyl cis-trans isomerase A (Homo sapiens (Human)) | BDBM50230293 (CHEMBL4082253) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid PDB UniChem Patents Similars | PDB Article PubMed | 795 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selcia Ltd. Curated by ChEMBL | Assay Description Inhibition of full length recombinant human N-terminal His8-tagged Cyclophilin A (1 to 169 residues) expressed in Escherichia coli BL21(DE3) using Su... | J Med Chem 60: 1000-1017 (2017) Article DOI: 10.1021/acs.jmedchem.6b01329 BindingDB Entry DOI: 10.7270/Q2JQ137K | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM163042 (US9062004, 5 | US9670216, 13 4-Bromo-5-propylamino...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 4.80 | n/a | n/a | n/a | n/a | n/a | 25 |
ALLERGAN, INC. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce... | US Patent US9670216 (2017) BindingDB Entry DOI: 10.7270/Q2V98674 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM163050 (US9062004, 13) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 4.80 | n/a | n/a | n/a | n/a | n/a | n/a |
Allergan, Inc. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co... | US Patent US9062004 (2015) BindingDB Entry DOI: 10.7270/Q2BZ64SM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM163042 (US9062004, 5 | US9670216, 13 4-Bromo-5-propylamino...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.40 | n/a | n/a | n/a | n/a | n/a | 25 |
ALLERGAN, INC. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce... | US Patent US9670216 (2017) BindingDB Entry DOI: 10.7270/Q2V98674 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM163042 (US9062004, 5 | US9670216, 13 4-Bromo-5-propylamino...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.40 | n/a | n/a | n/a | n/a | n/a | n/a |
Allergan, Inc. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co... | US Patent US9062004 (2015) BindingDB Entry DOI: 10.7270/Q2BZ64SM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM163069 (US9062004, 36 | US9670216, 36 1-(2-Morpholin-4-yle...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Allergan, Inc. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co... | US Patent US9062004 (2015) BindingDB Entry DOI: 10.7270/Q2BZ64SM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM163069 (US9062004, 36 | US9670216, 36 1-(2-Morpholin-4-yle...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8.5 | n/a | n/a | n/a | n/a | n/a | 25 |
ALLERGAN, INC. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce... | US Patent US9670216 (2017) BindingDB Entry DOI: 10.7270/Q2V98674 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM163067 (US9062004, 34 | US9670216, 34 1-Propyl-5-(3,3,5,5-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 17 | n/a | n/a | n/a | n/a | n/a | 25 |
ALLERGAN, INC. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce... | US Patent US9670216 (2017) BindingDB Entry DOI: 10.7270/Q2V98674 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM163041 (US9062004, 4 | US9670216, 4 4-Chloro-5-dimethylami...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 17 | n/a | n/a | n/a | n/a | n/a | 25 |
ALLERGAN, INC. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce... | US Patent US9670216 (2017) BindingDB Entry DOI: 10.7270/Q2V98674 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM163041 (US9062004, 4 | US9670216, 4 4-Chloro-5-dimethylami...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 17 | n/a | n/a | n/a | n/a | n/a | n/a |
Allergan, Inc. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co... | US Patent US9062004 (2015) BindingDB Entry DOI: 10.7270/Q2BZ64SM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM163067 (US9062004, 34 | US9670216, 34 1-Propyl-5-(3,3,5,5-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 17 | n/a | n/a | n/a | n/a | n/a | n/a |
Allergan, Inc. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co... | US Patent US9062004 (2015) BindingDB Entry DOI: 10.7270/Q2BZ64SM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM163065 (US9062004, 31 | US9670216, 32 4-Chloro-5-(2-diethy...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
Allergan, Inc. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co... | US Patent US9062004 (2015) BindingDB Entry DOI: 10.7270/Q2BZ64SM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM163065 (US9062004, 31 | US9670216, 32 4-Chloro-5-(2-diethy...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | 25 |
ALLERGAN, INC. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce... | US Patent US9670216 (2017) BindingDB Entry DOI: 10.7270/Q2V98674 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM163051 (US9062004, 15 | US9670216, 16 4-Chloro-2-(3,5-dime...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 22 | n/a | n/a | n/a | n/a | n/a | 25 |
ALLERGAN, INC. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce... | US Patent US9670216 (2017) BindingDB Entry DOI: 10.7270/Q2V98674 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM163051 (US9062004, 15 | US9670216, 16 4-Chloro-2-(3,5-dime...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 22.4 | n/a | n/a | n/a | n/a | n/a | n/a |
Allergan, Inc. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co... | US Patent US9062004 (2015) BindingDB Entry DOI: 10.7270/Q2BZ64SM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM50005908 (CHEMBL3234707 | US9062004, 14 | US9670216, 14 4-Br...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | 42 | n/a | n/a | n/a | n/a | n/a | n/a |
Allergan, Inc. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co... | US Patent US9062004 (2015) BindingDB Entry DOI: 10.7270/Q2BZ64SM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM50005908 (CHEMBL3234707 | US9062004, 14 | US9670216, 14 4-Br...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | US Patent | n/a | n/a | 42 | n/a | n/a | n/a | n/a | n/a | 25 |
ALLERGAN, INC. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce... | US Patent US9670216 (2017) BindingDB Entry DOI: 10.7270/Q2V98674 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM163045 (US9062004, 8 | US9670216, 8 5-Propylamino-2-(3,3,5...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 68 | n/a | n/a | n/a | n/a | n/a | 25 |
ALLERGAN, INC. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce... | US Patent US9670216 (2017) BindingDB Entry DOI: 10.7270/Q2V98674 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM163045 (US9062004, 8 | US9670216, 8 5-Propylamino-2-(3,3,5...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 68 | n/a | n/a | n/a | n/a | n/a | n/a |
Allergan, Inc. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co... | US Patent US9062004 (2015) BindingDB Entry DOI: 10.7270/Q2BZ64SM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM163048 (US9062004, 11 | US9670216, 11 4-Chloro-5-(2-morpho...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 83 | n/a | n/a | n/a | n/a | n/a | 25 |
ALLERGAN, INC. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce... | US Patent US9670216 (2017) BindingDB Entry DOI: 10.7270/Q2V98674 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM163048 (US9062004, 11 | US9670216, 11 4-Chloro-5-(2-morpho...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 83 | n/a | n/a | n/a | n/a | n/a | n/a |
Allergan, Inc. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co... | US Patent US9062004 (2015) BindingDB Entry DOI: 10.7270/Q2BZ64SM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM163071 (US9062004, 38 | US9670216, 38 1-(2-Dimethylaminoet...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 105 | n/a | n/a | n/a | n/a | n/a | 25 |
ALLERGAN, INC. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce... | US Patent US9670216 (2017) BindingDB Entry DOI: 10.7270/Q2V98674 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM163071 (US9062004, 38 | US9670216, 38 1-(2-Dimethylaminoet...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 105 | n/a | n/a | n/a | n/a | n/a | n/a |
Allergan, Inc. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co... | US Patent US9062004 (2015) BindingDB Entry DOI: 10.7270/Q2BZ64SM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 1 (Homo sapiens (Human)) | BDBM163050 (US9062004, 13) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 174 | n/a | n/a | n/a | n/a | n/a | n/a |
Allergan, Inc. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co... | US Patent US9062004 (2015) BindingDB Entry DOI: 10.7270/Q2BZ64SM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 1 (Homo sapiens (Human)) | BDBM163042 (US9062004, 5 | US9670216, 13 4-Bromo-5-propylamino...) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 174 | n/a | n/a | n/a | n/a | n/a | 25 |
ALLERGAN, INC. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce... | US Patent US9670216 (2017) BindingDB Entry DOI: 10.7270/Q2V98674 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM163049 (US9062004, 12 | US9670216, 12 4-Chloro-5-(2-dimeth...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 204 | n/a | n/a | n/a | n/a | n/a | n/a |
Allergan, Inc. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co... | US Patent US9062004 (2015) BindingDB Entry DOI: 10.7270/Q2BZ64SM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM163049 (US9062004, 12 | US9670216, 12 4-Chloro-5-(2-dimeth...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 204 | n/a | n/a | n/a | n/a | n/a | 25 |
ALLERGAN, INC. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce... | US Patent US9670216 (2017) BindingDB Entry DOI: 10.7270/Q2V98674 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 1 (Homo sapiens (Human)) | BDBM163069 (US9062004, 36 | US9670216, 36 1-(2-Morpholin-4-yle...) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 219 | n/a | n/a | n/a | n/a | n/a | n/a |
Allergan, Inc. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co... | US Patent US9062004 (2015) BindingDB Entry DOI: 10.7270/Q2BZ64SM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 1 (Homo sapiens (Human)) | BDBM163069 (US9062004, 36 | US9670216, 36 1-(2-Morpholin-4-yle...) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 219 | n/a | n/a | n/a | n/a | n/a | 25 |
ALLERGAN, INC. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce... | US Patent US9670216 (2017) BindingDB Entry DOI: 10.7270/Q2V98674 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM163068 (US9062004, 35 | US9670216, 35 2-Propyl-5-(3,3,5,5-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 240 | n/a | n/a | n/a | n/a | n/a | 25 |
ALLERGAN, INC. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce... | US Patent US9670216 (2017) BindingDB Entry DOI: 10.7270/Q2V98674 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM163068 (US9062004, 35 | US9670216, 35 2-Propyl-5-(3,3,5,5-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 240 | n/a | n/a | n/a | n/a | n/a | n/a |
Allergan, Inc. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co... | US Patent US9062004 (2015) BindingDB Entry DOI: 10.7270/Q2BZ64SM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 1 (Homo sapiens (Human)) | BDBM163067 (US9062004, 34 | US9670216, 34 1-Propyl-5-(3,3,5,5-...) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 257 | n/a | n/a | n/a | n/a | n/a | n/a |
Allergan, Inc. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co... | US Patent US9062004 (2015) BindingDB Entry DOI: 10.7270/Q2BZ64SM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 1 (Homo sapiens (Human)) | BDBM163067 (US9062004, 34 | US9670216, 34 1-Propyl-5-(3,3,5,5-...) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 257 | n/a | n/a | n/a | n/a | n/a | 25 |
ALLERGAN, INC. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce... | US Patent US9670216 (2017) BindingDB Entry DOI: 10.7270/Q2V98674 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM163040 (US9062004, 3 | US9670216, 3 4-Chloro-5-methylamino...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 355 | n/a | n/a | n/a | n/a | n/a | 25 |
ALLERGAN, INC. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce... | US Patent US9670216 (2017) BindingDB Entry DOI: 10.7270/Q2V98674 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM163040 (US9062004, 3 | US9670216, 3 4-Chloro-5-methylamino...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 355 | n/a | n/a | n/a | n/a | n/a | n/a |
Allergan, Inc. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co... | US Patent US9062004 (2015) BindingDB Entry DOI: 10.7270/Q2BZ64SM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM163044 (US9062004, 7 | US9670216, 7 5-Dimethylamino-2-(3,3...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 380 | n/a | n/a | n/a | n/a | n/a | 25 |
ALLERGAN, INC. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce... | US Patent US9670216 (2017) BindingDB Entry DOI: 10.7270/Q2V98674 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM163044 (US9062004, 7 | US9670216, 7 5-Dimethylamino-2-(3,3...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 380 | n/a | n/a | n/a | n/a | n/a | n/a |
Allergan, Inc. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co... | US Patent US9062004 (2015) BindingDB Entry DOI: 10.7270/Q2BZ64SM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM163039 (US9062004, 2 | US9670216, 2 4,5-Dichloro-2-(3,3,5,...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 389 | n/a | n/a | n/a | n/a | n/a | n/a |
Allergan, Inc. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co... | US Patent US9062004 (2015) BindingDB Entry DOI: 10.7270/Q2BZ64SM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM163039 (US9062004, 2 | US9670216, 2 4,5-Dichloro-2-(3,3,5,...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 389 | n/a | n/a | n/a | n/a | n/a | 25 |
ALLERGAN, INC. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce... | US Patent US9670216 (2017) BindingDB Entry DOI: 10.7270/Q2V98674 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 1 (Homo sapiens (Human)) | BDBM163042 (US9062004, 5 | US9670216, 13 4-Bromo-5-propylamino...) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.02E+3 | n/a | n/a | n/a | n/a | n/a | 25 |
ALLERGAN, INC. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce... | US Patent US9670216 (2017) BindingDB Entry DOI: 10.7270/Q2V98674 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 1 (Homo sapiens (Human)) | BDBM163041 (US9062004, 4 | US9670216, 4 4-Chloro-5-dimethylami...) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.02E+3 | n/a | n/a | n/a | n/a | n/a | 25 |
ALLERGAN, INC. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce... | US Patent US9670216 (2017) BindingDB Entry DOI: 10.7270/Q2V98674 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 1 (Homo sapiens (Human)) | BDBM163041 (US9062004, 4 | US9670216, 4 4-Chloro-5-dimethylami...) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.02E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Allergan, Inc. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co... | US Patent US9062004 (2015) BindingDB Entry DOI: 10.7270/Q2BZ64SM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 1 (Homo sapiens (Human)) | BDBM163042 (US9062004, 5 | US9670216, 13 4-Bromo-5-propylamino...) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.02E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Allergan, Inc. US Patent | Assay Description Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co... | US Patent US9062004 (2015) BindingDB Entry DOI: 10.7270/Q2BZ64SM | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 156 total ) | Next | Last >> |